Contraline
CO
CO

Contraline

DR46Ahrefs DR: 46/100. Above median. Measured by Ahrefs. Median 44.Agent21Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Speed98Site Speed: 98/100. Top 25%. Measured by Google PageSpeed. Median 62.

Developing novel male contraceptives.

Website
2017ActiveCharlottesville, USA

About

Contraline is developing the future of male contraception, aiming to provide effective, safe, and reversible contraceptive options for men and couples. Their investigational products include NES/T, a daily topical gel designed to pause sperm production, and ADAM, a long-lasting, non-hormonal, and reversible implant. Contraline is committed to offering new choices for family planning that fit seamlessly into people's lives.

Key facts

At-a-glance profile data

Website
contraline.com
Headquarters
Charlottesville, Virginia, USA
Founded
2017
Total funding
$103M (Series B)
Business model
B2B2C

Funding rounds

Funding rounds raised by Contraline
DateRoundAmountLead investors
2 Jun 2026Series B$93MBVF Partners L.P., RA Capital
1 Sept 2021Seed$10MRock Health

Tech stack

Detected on contraline.com, last scanned 4 Sept 2026. Run your own scan

Frontend
React
Analytics
Google Analytics 4, Segment
CDN
Vercel
Email provider
Google Workspace
Email marketing
Mailchimp
Add first review

Frequently asked

How much funding has Contraline raised?

Contraline has raised a total of $103M in funding. The most recent round on record is Series B.